Conflict as a multiplier of disease: The Ebola outbreak in the Democratic Republic of the Congo


The intersection between armed conflicts and infectious diseases may once again put global health security at risk. The current Ebola outbreak in the Democratic Republic of the Congo highlights a convergence that is difficult to manage. The Democratic Republic of the Congo and neighboring Uganda declared an outbreak on May 15, 2026, while the World Health Organization (from) was declared a Public Health Emergency of International Concern just 48 hours later. Africa Centers for Disease Control and Prevention (CDC) I followed suitdeclaring it a Public Health Emergency of Continental Security (PHECS). The outbreak likely began much earlier, with reports of a mysterious illness emerging in the gold mining town of Mongbwalu and surrounding areas as early as April. Current estimates are 138 deaths and 695 confirmed cases. The ongoing outbreak is characterized by three main factors: poor community disease surveillance, the impacts of conflict and displacement on health system performance, and the lack of an approved vaccine or specific therapeutic agent. Collectively, these factors make the outbreak vulnerable to becoming uncontrollable and underscore the need for better preparedness.
Bundibugyovirus and delayed detection
Ebola virus disease occurs when a person is infected with a virus that causes hemorrhagic fever and severe tissue inflammation and damage that, if left untreated, can be life-threatening. In humans, Three different virusesEbola virus, Sudan virus, and Bundibugyo virus are known to cause large-scale Ebola outbreaks. The largest and most severe Ebola outbreak was the West Africa outbreak in 2014-2016, during which more than 28,600 casesQ It has been reported. the Current outbreak It is attributed to Bundibugyovirus (BDBV), the third time it has been discovered in humans; Previous outbreaks occurred in 2007 and 2012. Reports indicate that the fatality rate for BDB is between 30 and 50 percent, which is lower than the rate of the outbreak in West Africa, which had a significant spread. Death of Rathe From 63 percent.
This highlights the need for BDBV-specific or universal filovirus diagnostics at the point of care as part of the Ebola preparedness system. The delay in discovery of BDBV, coupled with its nonspecific clinical presentation, has led to undetected transmission events.
These viruses are of animal origin, and studies indicate that fruit bats are in the family Cryptopods It is their natural reservoir. Transition It is happening When a person is in close contact with the blood or secretions of animals carrying the virus. Human-to-human transmission occurs in close contact settings such as health care SettingsWhen a person comes into direct contact with blood or body fluids from a sick or deceased person, as well as through contaminated inanimate objects and surfaces. Symptoms appear 2 to 21 days after infection They overlap at first With other types of viral hemorrhagic fevers and diseases such as malaria, which further complicates the diagnosis.
Reports of a mysterious illness in the remote gold-mining town of Mongbwalu in Ituri Province, Democratic Republic of the Congo, that had already claimed lives, emerged in April 2026, but surveillance and diagnosis were limited. Late recognition From the Ebola outbreak. GeneXpert diagnostic kits failed to detect BDBV because they were designed to detect Ebola virus, which could allow transmission to go undetected. Later, pan-filovirus PCR assays—assays that detect a wide range of viruses—were used, along with sequencing methods, to detect BDBV cases. Obtaining the diagnostic kits and reagents needed for sequencing encountered logistical delays because they required specialized equipment and trained personnel.
This highlights need to BDBV-specific or universal filovirus diagnosis at the point of care as part of the Ebola preparedness system. The delay in discovery of BDBV, coupled with its nonspecific clinical presentation, has led to undetected transmission events. This is worrying because of the late detection events It’s already been done associated with a broader and longer Ebola outbreak.
Spread risks
The outbreak also points to the need for a deeper understanding of the interconnectedness of humans, plants, animals and the planet, or a One Health approach. While fruit bats are the natural reservoir of BDBV, there is a shortage of it Conclusive scientific evidence To explain how zoonotic spillover events occur, whether there are any intermediate hosts, and the precise mechanisms of transmission from hosts to humans. Ituri Province has a rich bat biodiversity, with caves and dense forest canopies serving as roosting sites for bats. Furthermore, the area contains artisanal gold mining communities and is highly populated. Habitat loss and degradation have likely and are likely to have contributed to biodiversity loss responsible For frequent indirect events in the area. Cross-border movement through this porous region likely spread the disease to Uganda, which it did 19 cases of BDBV have been reported and two deaths as of June 10, 2026. Studies on the interaction between the virus and humans show that there is a close connection Ecosystem Between bats and humans it can facilitate spillover events. For example, close physical contact with bats through droppings, contaminated fruit, or Bush meat It can facilitate transmission of infection.
Conflict and the erosion of health security
Democratic Republic of the Congo as well Tagged by Conflict and insecurity since the 1994 Rwandan genocide. The region is dominated by ethnic tensions and political violence, especially in Ituri, located along the border between the Democratic Republic of the Congo and Rwanda, over land resources and mineral extraction between armed and ethnic organizations. Large reserves of rare earths and minerals have motivated more groups, including American and Chinese multinational mining companies, to become involved in the conflict. In addition to six million deaths Since 1996it was approximately 5.6 million people Displaced Within the Democratic Republic of the Congo, an estimated 26.5 million people suffer from it Food insecurity. Against this backdrop, the Democratic Republic of the Congo has also experienced repeated Ebola outbreaks; the continuous The outbreak is the 17th outbreak of Ebola in the Democratic Republic of the Congo.
Large reserves of rare earths and minerals have motivated more groups, including American and Chinese multinational mining companies, to become involved in the conflict. In addition to the six million deaths since 1996, nearly 5.6 million people have been displaced within the Democratic Republic of the Congo, and an estimated 26.5 million people are food insecure.
Although a Peace agreement– The Washington Peace Accords for Peace and Prosperity – between the Democratic Republic of the Congo and Rwanda that were signed in 2025, and clashes are still ongoing between the M23 Movement, an armed group supported by Rwanda, and the Democratic Republic of the Congo. Conflict cycles I have weakened Health infrastructure and linking roads necessary to access health services. Security measures impede the movement of health workers, food and medical supplies, while attacks on healthcare facilities have prevented access to critical health needs. The Democratic Republic of the Congo was the African country hardest hit by USAID cuts, creating gaps in disease surveillance and monitoring measures. The displacement of people from the conflict-affected area makes contact tracing difficult. Disturbances in economic activity, such as trade and agriculture, have exacerbated poverty, contributing to severe food insecurity in the country. Political violence has created an environment of fear, mistrust, and misinformation and disinformation, hampering measures to contain the spread of the virus.
For example, mistrust has fueled debate about the origin of gender-based violence – calling into question its existence, raising doubts about whether the presence of aid workers in the area is intended to help local communities or access the region’s minerals, and whether the outbreak is the result of an accident. deliberate Biological weapons attack. As a result, suspected individuals have fled Ebola triage centers, making contact tracing and attempts to reduce transmission difficult. These tensions It has resulted In attacks on medical personnel and hospital infrastructure. Previous Ebola outbreaks He stressed the importance To detect and monitor, strong, coordinated and community-based responses helped contain the virus and stop its spread. This is it necessary Because early supportive care is the only life-saving intervention for BDBV infection.
The importance of deploying precautionary measures within cultural contexts is highlighted in Dorothy Crawford’s book, Ebola: profile of the deadly virus.
the importance The importance of deploying precautionary measures within cultural contexts is highlighted in Dorothy Crawford’s book, Ebola: profile of the deadly virus. This includes Educating people On the need for safe burial practices, implementing sorting systems with transparent dividers, promoting behaviors that reduce exposure to potential transmission sites, and providing Reassurance This spread can be contained relatively easily compared to airborne viruses.
Closing the readiness gap
There are no approved vaccines or treatments for BDBV. This indicates a discrepancy in preparedness: the licensed Ebola vaccine (for the Ebola virus), Ervibo, is being provided limited Cross-protection against other Ebola viruses, while the limited number of BDBV outbreaks has provided little opportunity or incentive for the development and evaluation of vaccine candidates. However, WHO expert and advisory groups have done so Recommended That several candidate treatments and vaccines be evaluated in clinical trials as a priority. These treatments include monoclonal antibodies such as MBP134 and Maftivimab®, the antiviral remdesivir, and post-exposure prophylaxis. Research vaccine candidates include the rVSV Bundibugyo vaccine (developed by the International AIDS Vaccine Initiative) and the ChAdOx1 Bundibugyo vaccine candidate (developed by the University of Oxford and the Serum Institute of India). The Coalition for Epidemic Preparedness Innovations (CEPI) was announced. Plan to invest $60 million in rapid R&D for these two vaccine candidates, as well as Moderna’s BDBV mRNA vaccine candidate, while Gavi, the vaccine alliance, will add $50 million to Guaranteed Production and access to large quantities. He has a pandemic fund pledge $220.6 million to fill gaps in outbreak response.
There are no approved vaccines or treatments for BDBV. This demonstrates a paradox in preparedness: the licensed Ebola vaccine (for Ebola virus), Ervibo, provides limited overall protection against other Ebola viruses, while the limited number of BDBV outbreaks has provided little opportunity or incentive to develop and evaluate vaccine candidates.
conclusion
US Centers for Disease Control and Prevention (CDC) Models They predict that the ongoing outbreak could become as large as the 2014-2016 West Africa outbreak. Until a safe and effective vaccine is approved for use against BDB virus, community-focused public health interventions must be a priority. The Democratic Republic of the Congo presents a unique challenge, as severely weak health infrastructure, armed conflict, and displacement can frustrate efforts to contain the outbreak of the virus. The use of rapid point-of-care diagnostics for BDB to enhance surveillance and detection, along with increasing awareness of behaviors and practices that facilitate human-to-human transmission, remains critical at this stage.
Lakshmi Ramakrishnan He is an associate fellow at the Center for New Economic Diplomacy at the Observer Research Foundation.
The author acknowledges the use of ChatGPT-5.5 (OpenAI) to identify duplicate sections and suggest word count reductions.
The opinions expressed above are those of the author(s). ORF research and analysis is now available on Telegram! Click here To access our curated content – blogs, longforms, and interviews.




